AG
TEVA icon

Artal Group’s Teva Pharmaceuticals TEVA Stock Holding History

Artal Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-450,000
Closed -$24.1M – 80
2016
Q1 		$24.1M Hold
450,000
– – 0.47% 18
2015
Q4 		$29.5M Hold
450,000
– – 0.55% 20
2015
Q3 		$25.4M Hold
450,000
– – 0.57% 28
2015
Q2 		$26.6M Sell
450,000
-150,000
-25% -$9.25M 1.14% 28
2015
Q1 		$37.4M Buy
600,000
+100,000
+20% +$5.81M 1.73% 17
2014
Q4 		$28.8M Sell
500,000
-100,000
-17% -$5.57M 1.01% 19
2014
Q3 		$32.3M Sell
600,000
-100,000
-14% -$5.3M 1.19% 15
2014
Q2 		$36.7M Buy
700,000
+100,000
+17% +$5.11M 1.48% 13
2014
Q1 		$31.7M Sell
600,000
-100,000
-14% -$4.62M 1.15% 19
2013
Q4 		$28.1M Hold
700,000
– – 1.01% 18
2013
Q3 		$26.4M Hold
700,000
– – 0.86% 15
2013
Q2 		$27.4M Buy
+700,000
New +$27.3M 0.86% 17

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return